EMT as the ultimate survival mechanism of cancer cells
- PMID: 22406545
- DOI: 10.1016/j.semcancer.2012.02.013
EMT as the ultimate survival mechanism of cancer cells
Abstract
Epithelial cancers make up the vast majority of cancer types and, during the transition from benign adenoma to malignant carcinoma and metastasis, epithelial tumor cells acquire a de-differentiated, migratory and invasive behavior. This process of epithelial-mesenchymal transition (EMT) goes along with dramatic changes in cellular morphology, the loss and remodeling of cell-cell and cell-matrix adhesions, and the gain of migratory and invasive capabilities. EMT itself is a multistage process, involving a high degree of cellular plasticity and a large number of distinct genetic and epigenetic alterations, as fully differentiated epithelial cells convert into poorly differentiated, migratory and invasive mesenchymal cells. In the past years, a plethora of genes have been identified that are critical for EMT and metastasis formation. Notably, the EMT process not only induces increased cancer cell motility and invasiveness but also allows cancer cells to avoid apoptosis, anoikis, oncogene addiction, cellular, senescence and general immune defense. Notably, EMT seems to play a critical role in the generation and maintenance of cancer stem cells, highly consistent with the notion that metastatic cells carry the ability to initiate new tumors.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
[Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].Clin Calcium. 2011 Mar;21(3):411-7. Clin Calcium. 2011. PMID: 21358063 Review. Japanese.
-
Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis.Exp Cell Res. 2013 Jan 15;319(2):160-9. doi: 10.1016/j.yexcr.2012.07.019. Epub 2012 Aug 1. Exp Cell Res. 2013. PMID: 22935683 Review.
-
[Epithelial-mesenchymal transition in cancer progression].Postepy Biochem. 2009;55(2):121-8. Postepy Biochem. 2009. PMID: 19824467 Review. Polish.
-
MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.Cancer Gene Ther. 2012 Nov;19(11):723-30. doi: 10.1038/cgt.2012.58. Epub 2012 Sep 14. Cancer Gene Ther. 2012. PMID: 22975591 Review.
-
[Tumour stem cells and metastasis].Zentralbl Chir. 2010 Aug;135(4):318-22. doi: 10.1055/s-0030-1247470. Epub 2010 Aug 30. Zentralbl Chir. 2010. PMID: 20806134 Review. German.
Cited by
-
FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 Transcription.Front Oncol. 2021 Feb 25;11:605025. doi: 10.3389/fonc.2021.605025. eCollection 2021. Front Oncol. 2021. PMID: 33718155 Free PMC article.
-
Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells.Cancer Med. 2015 Apr;4(4):551-64. doi: 10.1002/cam4.412. Epub 2015 Jan 30. Cancer Med. 2015. PMID: 25641933 Free PMC article.
-
Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.J Biosci. 2016 Jun;41(2):229-36. doi: 10.1007/s12038-016-9603-3. J Biosci. 2016. PMID: 27240983
-
Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future.Front Oncol. 2022 Aug 15;12:976557. doi: 10.3389/fonc.2022.976557. eCollection 2022. Front Oncol. 2022. PMID: 36046036 Free PMC article. Review.
-
Targeting the Endothelin-1 pathway to reduce invasion and chemoresistance in gallbladder cancer cells.Cancer Cell Int. 2023 Dec 10;23(1):318. doi: 10.1186/s12935-023-03145-9. Cancer Cell Int. 2023. PMID: 38072958 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous